AJMC® in the Press, March 31, 2023

Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their pharmacies through network exclusions and targeted marketing.

Jessica Tracy, head of Growth and Partnerships at Enthea, shares how employers and unions can support mental health and address access barriers to evidence-based ketamine treatments.

Mutations in one of the first human-isolated strains of H5N1 bird flu in the US were identified by the Texas Biomedical Research Institute.

The editors in chief of The American Journal of Managed Care® discuss the key managed care research and news from 2024 and look forward to the journal’s upcoming 30th anniversary.

The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.

Experts stress that persons wanting to donate blood should not stop any medications they are on, with some deferrals being permanent and others temporary.